- Journey Medical press release (NASDAQ:DERM): Q1 GAAP EPS of -$0.18 beats by $0.06.
- Revenue of $13.14M (+0.8% Y/Y) beats by $1.05M.
- At March 31, 2025, the company had $21.1 million in cash and cash equivalents as compared to $20.3 million in cash and cash